FOR IMMEDIATE RELEASE
Release No. 98-28
June 4, 1998
Contact:
For the 151st APA Annual Meeting program, new research abstract book, abstracts on disk, or syllabus, call 202-682-6325. To set up an interview with a presenter in Toronto, you may leave a message for that person with the annual meeting message center at 416-585-3620. For specific questions the Annual Meeting press room number is 416-585-3606.
APA ANNUAL MEETING
HIGHLIGHTS THURSDAY, JUNE 4, 1998
Note: All presentations are embargoed from broadcast, publication, and electronic dispersement until the day of the presentation. Only the presenter with authorization from the chairperson of his/her session can agree to an earlier release. If an embargo is lifted with these provisions, Public Affairs staff will post a notification in the Press Room and on the electronic news and information web sites read by journalists to ensure that no one outlet is granted an exclusive.
Thursday:
APA Communications Center opens at 8:00 a.m. and closes at 12:00 noon It is located in the lower level of the Toronto Convention Centre.
PROGRAM HIGHLIGHTS
New Research Highlights
10:00 a.m.
Black Women Receive Fewer SSRI Antidepressants, New Research 651 Andrew A. Nierenberg, M.D., Massachusetts General Hospital. Black women in this study were less likely to be prescribed SSRI antidepressants than Caucasian women. Further study is needed as to why. 10:00 a.m. Cancer Incidence Following the Death of an Adult Son, New Research 657 Robert Kohn, M.D., Butler Hospital, Providence, RI. A study of 6,284 Jewish Israelis who lost an adult son in the 1973 Yom Kippur War were studied by the National Cancer Institute for an incidence of cancer and stress.
Session Highlights
9:00 a.m. - 10:30 a.m.
Executive Distress: Three Treatment Models, Issue Workshop 105 Jeffrey P. Kahn, M.D., Chairperson. Discussion will be a comprehensive synthesis of evaluation and treatment issues for executives. Greater understanding of the business issues discussed is also valuable in the treatment of any employed patient. 2:00 p.m. - 5:00 p.m. Results of the NIDA Collaborative Cocaine Treatment Study, Symposium 105, Michael E. Thase, M.D., Chairperson. Rationale of the NIDA collaborative cocaine treatment study by Lynne Siqueland, Ph.D., University of Pennsylvania; drug outcome of the NIDA collaborative cocaine treatment study by Paul Crits-Christoph, Ph.D., University of Pennsylvania
###
RSS